Acura Pharmaceuticals Inc.
07/26/2024 | Press release | Distributed by Public on 07/26/2024 13:52
New Financial Obligation Form 8 K
Amended Loan Schedule to Secured Promissory Note dated November 10, 2022
between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC
| Date | Principal | Aggregated Principal | ||||||
| Original Secured Promissory Note | 11/10/2022 | $2,319,279 | $2,319,279 | |||||
| Additional loans to be included: | ||||||||
| Loan #1 | 12/22/2022 | $250,000 | $2,569,279 | |||||
| Loan #2 | 1/19/2023 | $250,000 | $2,819,279 | |||||
| Loan #3 | 2/22/2023 | $250,000 | $3,069,279 | |||||
| Loan #4 | 3/20/2023 | $250,000 | $3,319,279 | |||||
| Loan #5 | 5/19/2023 | $150,000 | $3,469,279 | |||||
| Loan #6 | 7/10/2023 | $200,000 | $3,669,279 | |||||
| Loan #7 | 7/28/2023 | $250,000 | $3,919,279 | |||||
| Loan #8 | 8/30/2023 | $250,000 | $4,169,279 | |||||
| Loan #9 | 10/11/2023 | $250,000 | $4,419,279 | |||||
| Loan #10 | 12/04/2023 | $250,000 | $4,669,279 | |||||
| Loan #11 | 1/08/2024 | $250,000 | $4,919,279 | |||||
| Loan #12 | 2/14/2024 | $250,000 | $5,169,279 | |||||
| Loan #13 | 3/14/2024 | $250,000 | $5,419,279 | |||||
| Loan #14 | 5/10/2024 | $200,000 | $5,619,279 | |||||
| Loan #15 | 6/03/2024 | $75,000 | $5,694,279 | |||||
| Loan #16 | 6/14/2024 | $200,000 | $5,894,279 | |||||
| Loan #17 | 7/03/2024 | $150,000 | $6,044,279 | |||||
| Loan #18 | 7/22/2024 | $100,000 | $6,144,279 |
ACURA PHARMACEUTICALS, INC.
By: /s/ Robert A. Seiser
Robert A. Seiser
Vice President & Treasurer
Date: July 22, 2024